Načítá se...
Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer
PURPOSE: We previously found that the risk of invasive breast cancer varied according to the progestagen component of combined postmenopausal hormone therapy (CHT): progesterone, dydrogesterone, or other progestagens. We conducted the present study to assess how these CHTs were associated with histo...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Clinical Oncology
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2346534/ https://ncbi.nlm.nih.gov/pubmed/18323549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.13.4338 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|